• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Roundhill GLP-1 & Weight Loss ETF (NQ:OZEM)

    30.07 UNCHANGED
    Streaming Delayed Price Updated: 4:15 PM EDT, Mar 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 30.07
    Bid (Size) 12.09 (100)
    Ask (Size) 33.44 (300)
    Prev. Close 30.07
    Today's Range 30.07 - 30.07
    52wk Range 20.01 - 37.15
    Shares Outstanding N/A
    Dividend Yield 1.36%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Eli Lilly’s Diabetes Pill Outperforms Oral Semaglutide in Phase 3 Trial ↗
    Investors are closely watching the oral GLP-1 race as competition intensifies across the sector. 
    Via Stocktwits
    News headline image
    Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes ↗
    Novo Nordisk will lead global development, regulatory approval, manufacturing, and commercialization of the resulting products. 
    Via Stocktwits

    Performance

    YTD
    -12.4%
    -12.4%
    1 Month
    -15.1%
    -15.1%
    3 Month
    -12.7%
    -12.7%
    6 Month
    +8.9%
    +8.9%
    1 Year
    +23.1%
    +23.1%

    More News

    Read More
    Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report ↗
    Via Stocktwits
    News headline image
    Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗
    Via Stocktwits
    News headline image
    HIMS New $49 Pill Lifts Stock 10%, But Why Are NVO, LLY Stocks Falling? ↗
    Via Stocktwits
    Topics Intellectual Property
    Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today ↗
    Via Stocktwits
    News headline image
    Novo Awaits FDA Call On Higher-Dose Wegovy In Early 2026 – NVO Stock Extends Decline Pre-Market On Weak Guidance ↗
    Via Stocktwits
    Topics Intellectual Property
    News headline image
    LLY Stock Surges Pre-Market: Obesity, Diabetes Drugs Drive Strong FY26 Outlook ↗
    Via Stocktwits
    News headline image
    Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
    Via MarketBeat
    Topics ETFs
    News headline image
    Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗
    Via Benzinga
    Topics ETFs
    News headline image
    Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    Eli Lilly's Blockbuster Obesity Drugs Miss Sales Estimates Again, But Investors Cheer Q4 Earnings Beat ↗
    Via Stocktwits
    News headline image
    Eli Lilly Gets Wall Street Backing After Tuesday’s Turmoil, Stock Rises Premarket As Retail Stays Bullish ↗
    Via Stocktwits
    Topics Earnings
    News headline image
    Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight-Loss Drug Sales Miss, But Retail Bullish On 2025 Projections ↗
    Via Stocktwits
    Topics Earnings
    News headline image
    Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares ↗
    Via Benzinga
    Topics ETFs
    News headline image
    EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗
    Via Benzinga
    News headline image
    ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential ↗
    Via Benzinga
    Topics ETFs
    News headline image
    New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk ↗
    Via Benzinga
    Topics ETFs
    News headline image
    Tesla (TSLA) Stock Drops as Glass Lewis Urges Against Elon Musk’s Pay Package ↗
    Via InvestorPlace
    News headline image
    Campbell Soup Layoffs 2024: What to Know About New Campbell Job Cuts ↗
    Via InvestorPlace
    Topics Workforce
    News headline image
    OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF ↗
    Via InvestorPlace
    Topics ETFs
    News headline image
    South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next ↗
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic ↗
    Via Benzinga
    Topics ETFs

    Frequently Asked Questions

    Is Roundhill GLP-1 & Weight Loss ETF publicly traded?
    Yes, Roundhill GLP-1 & Weight Loss ETF is publicly traded.
    What exchange does Roundhill GLP-1 & Weight Loss ETF trade on?
    Roundhill GLP-1 & Weight Loss ETF trades on the Nasdaq Stock Market
    What is the ticker symbol for Roundhill GLP-1 & Weight Loss ETF?
    The ticker symbol for Roundhill GLP-1 & Weight Loss ETF is OZEM on the Nasdaq Stock Market
    What is the current price of Roundhill GLP-1 & Weight Loss ETF?
    The current price of Roundhill GLP-1 & Weight Loss ETF is 30.07
    When was Roundhill GLP-1 & Weight Loss ETF last traded?
    The last trade of Roundhill GLP-1 & Weight Loss ETF was at 03/20/26 04:15 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.